BELYSSE GROUP NV (BELYS.BR) Fundamental Analysis & Valuation

EBR:BELYS • BE0974314461

Current stock price

0.645 EUR
-0.01 (-0.77%)
Last:

This BELYS.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BELYS.BR Profitability Analysis

1.1 Basic Checks

  • In the past year BELYS has reported negative net income.
  • In the past year BELYS had a positive cash flow from operations.
  • In the past 5 years BELYS reported 4 times negative net income.
  • Of the past 5 years BELYS 4 years had a positive operating cash flow.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.02%, BELYS is in line with its industry, outperforming 42.42% of the companies in the same industry.
  • BELYS has a worse Return On Equity (-0.07%) than 60.61% of its industry peers.
  • The Return On Invested Capital of BELYS (6.48%) is better than 72.73% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BELYS is below the industry average of 9.69%.
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROIC 6.48%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • Looking at the Operating Margin, with a value of 6.94%, BELYS is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
  • BELYS's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 61.34%, BELYS belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
  • BELYS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.94%
PM (TTM) N/A
GM 61.34%
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BELYS.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BELYS is destroying value.
  • Compared to 1 year ago, BELYS has about the same amount of shares outstanding.
  • Compared to 1 year ago, BELYS has an improved debt to assets ratio.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 0.25, we must say that BELYS is in the distress zone and has some risk of bankruptcy.
  • BELYS has a Altman-Z score of 0.25. This is amonst the worse of the industry: BELYS underperforms 84.85% of its industry peers.
  • The Debt to FCF ratio of BELYS is 4.98, which is a neutral value as it means it would take BELYS, 4.98 years of fcf income to pay off all of its debts.
  • BELYS's Debt to FCF ratio of 4.98 is fine compared to the rest of the industry. BELYS outperforms 69.70% of its industry peers.
  • BELYS has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of BELYS (1.80) is worse than 87.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Altman-Z 0.25
ROIC/WACC0.6
WACC10.77%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.63 indicates that BELYS should not have too much problems paying its short term obligations.
  • BELYS has a Current ratio of 1.63. This is in the better half of the industry: BELYS outperforms 60.61% of its industry peers.
  • BELYS has a Quick Ratio of 1.63. This is a bad value and indicates that BELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 0.90, BELYS is doing good in the industry, outperforming 60.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 0.9
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BELYS.BR Growth Analysis

3.1 Past

  • The earnings per share for BELYS have decreased strongly by -100.85% in the last year.
  • The Revenue has decreased by -6.81% in the past year.
  • Measured over the past years, BELYS shows a small growth in Revenue. The Revenue has been growing by 0.43% on average per year.
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%

3.2 Future

  • Based on estimates for the next years, BELYS will show a decrease in Earnings Per Share. The EPS will decrease by -1.41% on average per year.
  • The Revenue is expected to grow by 0.36% on average over the next years.
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

5

4. BELYS.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Forward Earnings ratio of 3.48 indicates a rather cheap valuation of BELYS.
  • 96.97% of the companies in the same industry are more expensive than BELYS, based on the Price/Forward Earnings ratio.
  • BELYS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.83.
Industry RankSector Rank
PE N/A
Fwd PE 3.48
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BELYS is valued cheaper than 90.91% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BELYS indicates a rather cheap valuation: BELYS is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.73
EV/EBITDA 3.72
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BELYS.BR Dividend Analysis

5.1 Amount

  • No dividends for BELYS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BELYS.BR Fundamentals: All Metrics, Ratios and Statistics

BELYSSE GROUP NV

EBR:BELYS (3/16/2026, 10:03:55 AM)

0.645

-0.01 (-0.77%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-13
Earnings (Next)04-24
Inst Owners12.64%
Inst Owner ChangeN/A
Ins Owners5.56%
Ins Owner ChangeN/A
Market Cap23.18M
Revenue(TTM)270.29M
Net Income(TTM)-59.00K
Analysts84.44
Price Target1.63 (152.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.48
P/S 0.09
P/FCF 0.73
P/OCF 0.56
P/B 0.28
P/tB N/A
EV/EBITDA 3.72
EPS(TTM)0
EYN/A
EPS(NY)0.19
Fwd EY28.74%
FCF(TTM)0.88
FCFY136.15%
OCF(TTM)1.15
OCFY177.71%
SpS7.52
BVpS2.28
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROCE 7.91%
ROIC 6.48%
ROICexc 7.66%
ROICexgc 15.72%
OM 6.94%
PM (TTM) N/A
GM 61.34%
FCFM 11.68%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
ROICexc(3y)9.09%
ROICexc(5y)7.47%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.69%
ROCE(5y)7.3%
ROICexgc growth 3Y21.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.96%
ROICexc growth 5YN/A
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Debt/EBITDA 3.8
Cap/Depr 48.2%
Cap/Sales 3.56%
Interest Coverage 1.25
Cash Conversion 106.31%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 0.9
Altman-Z 0.25
F-Score4
WACC10.77%
ROIC/WACC0.6
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A
EBIT growth 1Y-18.43%
EBIT growth 3Y-4.83%
EBIT growth 5YN/A
EBIT Next Year68.18%
EBIT Next 3Y25.03%
EBIT Next 5YN/A
FCF growth 1Y114.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.99%
OCF growth 3YN/A
OCF growth 5YN/A

BELYSSE GROUP NV / BELYS.BR Fundamental Analysis FAQ

What is the fundamental rating for BELYS stock?

ChartMill assigns a fundamental rating of 3 / 10 to BELYS.BR.


Can you provide the valuation status for BELYSSE GROUP NV?

ChartMill assigns a valuation rating of 5 / 10 to BELYSSE GROUP NV (BELYS.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for BELYSSE GROUP NV?

BELYSSE GROUP NV (BELYS.BR) has a profitability rating of 3 / 10.


What is the financial health of BELYSSE GROUP NV (BELYS.BR) stock?

The financial health rating of BELYSSE GROUP NV (BELYS.BR) is 3 / 10.